Effects of antiarrhythmics and hypokalemia on the rate adaptation of cardiac repolarization

References

• Pueyo E, Husti Z, Hornyik T, et al. Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk. Am J Physiol Heart Circ Physiol. 2010;298:H1577–H1587.
   PubMed Web of Science ®Google Scholar
• Vos MA, Verduyn SC, Gorgels APM, et al. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block. Circulation. 1995;91:864–872.
   PubMed Web of Science ®Google Scholar
• Cuomo S, De Caprio L, Acanfora D, et al. Relationship between QT interval duration and exercise-induced ventricular arrhythmias. Eur Heart J. 1989;10:622–627.
   PubMed Web of Science ®Google Scholar
• Gill JS, Baszko A, Xia R, et al. Dynamics of the QT interval in patients with exercise-induced ventricular tachycardia in normal and abnormal hearts. Am Heart J. 1993;126:1357–1363.
   PubMed Web of Science ®Google Scholar
• Yi G, Crook R, Guo XH, et al. Exercise-induced changes in the QT interval duration and dispersion in patients with sudden cardiac death after myocardial infarction. Int J Cardiol. 1998;63:271–279.
   PubMed Web of Science ®Google Scholar
• Tavernier R, Jordaens L, Haerynck F, et al. Changes in the QT interval and its adaptation to rate, assessed with continuous electrocardiographic recordings in patients with ventricular fibrillation, as compared to normal individuals without arrhythmias. Eur Heart J. 1997;18:994–999.
   PubMed Web of Science ®Google Scholar
• Smetana P, Pueyo E, Hnatkova K, et al. Individual patterns of dynamic QT/RR relationship in survivors of acute myocardial infarction and their relationship to antiarrhythmic efficacy of amiodarone. J Cardiovasc Electrophysiol. 2004;15:1147–1154.
   PubMed Web of Science ®Google Scholar
• Viskin S, Postema PG, Bhuiyan ZA, et al. The response of the QT interval to the brief tachycardia provoked by standing: a bedside test for diagnosing long QT syndrome. J Am Coll Cardiol. 2010;55:1955–1961.
   PubMed Web of Science ®Google Scholar
• Collinsworth KA, Kalman SM, Harrison DC. The clinical pharmacology of lidocaine as an antiarrhythymic drug. Circulation. 1974;50:1217–1230.
   PubMed Web of Science ®Google Scholar
• Glaaser IW, Clancy CE. Cardiac Na+ channels as therapeutic targets for antiarrhythmic agents. Clin Exp Pharmacol Physiol. 2006;171:99–121.
   Google Scholar
• Frommeyer G, Eckardt L. Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms. Nat Rev Cardiol. 2016;13:36–47.
   PubMed Web of Science ®Google Scholar
• Osadchii OE. Flecainide attenuates rate adaptation of ventricular repolarization in guinea-pig heart. Scand Cardiovasc J. 2016;50:28–35.
   PubMed Web of Science ®Google Scholar
• Kadish AH, Weisman HF, Veltri EP, et al. Paradoxical effects of exercise on the QT interval in patients with polymorphic ventricular tachycardia receiving type Ia antiarrhythmic agents. Circulation. 1990;81:14–19.
   PubMed Web of Science ®Google Scholar
• Weiss JN, Qu Z, Shivkumar K. Electrophysiology of hypokalemia and hyperkalemia. Circ Arrhythm Electrophysiol. 2017;10:1–10.
   Web of Science ®Google Scholar
• Osadchii OE. Impact of hypokalemia on electromechanical window, excitation wavelength and repolarization gradients in guinea-pig and rabbit hearts. PLoS One. 2014;9:e105599.
   PubMed Web of Science ®Google Scholar
• Pezhouman A, Singh N, Song Z, et al. Molecular basis of hypokalemia-induced ventricular fibrillation. Circulation. 2015;132:1528–1537.
   PubMed Web of Science ®Google Scholar
• Faber GM, Rudy Y. Action potential and contractility changes in [Na+]i overloaded cardiac myocytes: a simulation study. Biophys J. 2000;78:2392–2404.
   PubMed Web of Science ®Google Scholar
• Williams BA, Dickenson DR, Beatch GN. Kinetics of rate-dependent shortening of action potential duration in guinea-pig ventricle; effects of IK1 and IKr blockade. Br J Pharmacol. 1999;126:1426–1436.
   PubMed Web of Science ®Google Scholar
• Kirchhof PF, Fabritz CL, Franz MR. Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects. Circulation. 1998;97:2567–2574.
   PubMed Web of Science ®Google Scholar
• Osadchii OE. Quinidine elicits proarrhythmic changes in ventricular repolarization and refractoriness in guinea-pig. Can J Physiol Pharmacol. 2013;91:306–315.
   PubMed Web of Science ®Google Scholar
• Osadchii OE. Procainamide and lidocaine produce dissimilar changes in ventricular repolarization and arrhythmogenicity in guinea-pig. Fundam Clin Pharmacol. 2014;28:382–393.
   PubMed Web of Science ®Google Scholar
• Salata JJ, Wasserstrom JA. Effects of quinidine on action potentials and ionic currents in isolated canine ventricular myocytes. Circ Res. 1988;62:324–337.
   PubMed Web of Science ®Google Scholar
• Komeichi K, Tohse N, Nakaya H, et al. Effects of N-acetylprocainamide and sotalol on ion currents in isolated guinea-pig ventricular myocytes. Eur J Pharmacol. 1990;187:313–322.
   PubMed Web of Science ®Google Scholar
• Aronsen JM, Skogestad J, Lewalle A, et al. Hypokalemia induces Ca2+ overload and Ca2+ waves in ventricular myocytes by reducing Na+–K+ ATPase α2 activity. J Physiol. 2015;593:1509–1521.
   PubMed Web of Science ®Google Scholar
• Almotrefi AA, Basco C, Moorji A, et al. Class I antiarrhythmic drug effects on ouabain binding to guinea-pig cardiac Na+-K+ ATPase. Can J Physiol Pharmacol. 1999;77:866–870.
   PubMed Web of Science ®Google Scholar
• Zhang YH, Hancox JC. Mode-dependent inhibition by quinidine of Na+-Ca2+ exchanger current from guinea-pig isolated ventricular myocytes. Clin Exp Pharmacol Physiol 2002;29:777–781.
   PubMed Web of Science ®Google Scholar
• Chiamvimonvat N, Chen-Izu Y, Clancy CE, et al. Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics. J Physiol. 2017;595:2229–2252.
   PubMed Web of Science ®Google Scholar
• Bueno-Orovio A, Hanson BM, Gill JS, et al. In vivo human left-to-right ventricular differences in rate adaptation transiently increase pro-arrhythmic risk following rate acceleration. PLoS One. 2012;7:e52234.
   PubMed Web of Science ®Google Scholar
• Varro A, Baczko I. Cardiac ventricular repolarization reserve: a principle for understanding drug-related proarrhythmic risk. Br J Pharmacol. 2011;164:14–36.
   PubMed Web of Science ®Google Scholar
• Fabritz L, Damke D, Emmerich M, et al. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3. Cardiovasc Res. 2010;87:60–72.
   PubMed Web of Science ®Google Scholar